NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|4505415|ref|NP_000894|]
View 

NAD(P)H dehydrogenase [quinone] 1 isoform a [Homo sapiens]

Protein Classification

NAD(P)H-dependent oxidoreductase( domain architecture ID 10006206)

NAD(P)H-dependent oxidoreductase which catalyzes the reduction or oxidation of a substrate coupled to the oxidation or reduction, respectively, of a nicotinamide adenine dinucleotide cofactor NAD(P)H or NAD(P)+

CATH:  3.40.50.360
EC:  1.-.-.-
PubMed:  25372605|7568029
SCOP:  3001217

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
5-216 4.97e-61

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


:

Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 191.21  E-value: 4.97e-61
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415    5 RALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDItgklkdpanfqypaesvlaYKEGHLSPD 84
Cdd:COG2249   1 KILIIYAHPDPSSFNAALAEAAAEGLEAAGHEVTVHDLYAEGFDPVLSAADF-------------------YRDGPLPID 61
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415   85 IVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAYTYAAMYDKGPFRSKKAVLSITTGGSGSMYSLQGIHGD 164
Cdd:COG2249  62 VAAEQELLLWADHLVFQFPLWWYSMPALLKGWIDRVLTPGFAYGYGGGYPGGLLKGKKALLVVTTGGPEEAYSRLGYGGP 141
                       170       180       190       200       210
                ....*....|....*....|....*....|....*....|....*....|..
gi 4505415  165 MNVILwpiQSGILHFCGFQVLEPQLTYSIGHTPADARIQILEGWKKRLENIW 216
Cdd:COG2249 142 IEELL---FRGTLGYCGMKVLPPFVLYGVDRSSDEERAAWLERVRELLAALA 190
 
Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
5-216 4.97e-61

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 191.21  E-value: 4.97e-61
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415    5 RALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDItgklkdpanfqypaesvlaYKEGHLSPD 84
Cdd:COG2249   1 KILIIYAHPDPSSFNAALAEAAAEGLEAAGHEVTVHDLYAEGFDPVLSAADF-------------------YRDGPLPID 61
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415   85 IVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAYTYAAMYDKGPFRSKKAVLSITTGGSGSMYSLQGIHGD 164
Cdd:COG2249  62 VAAEQELLLWADHLVFQFPLWWYSMPALLKGWIDRVLTPGFAYGYGGGYPGGLLKGKKALLVVTTGGPEEAYSRLGYGGP 141
                       170       180       190       200       210
                ....*....|....*....|....*....|....*....|....*....|..
gi 4505415  165 MNVILwpiQSGILHFCGFQVLEPQLTYSIGHTPADARIQILEGWKKRLENIW 216
Cdd:COG2249 142 IEELL---FRGTLGYCGMKVLPPFVLYGVDRSSDEERAAWLERVRELLAALA 190
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
5-212 3.39e-46

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 153.26  E-value: 3.39e-46
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415      5 RALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMnFNPIISRKDITGklkdpanfqypaesvLAYKEGhlSPD 84
Cdd:pfam02525   2 KILIINAHPRPGSFSSRLADALVEALKAAGHEVTVRDLYAL-FLPVLDAEDLAD---------------LTYPQG--AAD 63
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415     85 IVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAYTYAA-MYDKGPFRSKKAVLSITTGGSGSMYSLQGIHG 163
Cdd:pfam02525  64 VESEQEELLAADVIVFQFPLYWFSVPALLKGWIDRVLRAGFAFKYEEgGPGGGGLLGKKVLVIVTTGGPEYAYGKGGYNG 143
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|.
gi 4505415    164 -DMNVILWPIQsGILHFCGFQVLEPQLTYSI-GHTPADARIQILEGWKKRL 212
Cdd:pfam02525 144 fSLDELLPYLR-GILGFCGITDLPPFAVEGTaGPEDEAALAEALERYEERL 193
PRK09739 PRK09739
NAD(P)H oxidoreductase;
1-127 6.18e-15

NAD(P)H oxidoreductase;


Pssm-ID: 236620 [Multi-domain]  Cd Length: 199  Bit Score: 71.27  E-value: 6.18e-15
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415     1 MVGRRALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDitgklkdpanfqypaESVLAYKEGH 80
Cdd:PRK09739   1 MQSMRIYLVWAHPRHDSLTAKVAEAIHQRAQERGHQVEELDLYRSGFDPVLTPED---------------EPDWKNPDKR 65
                         90       100       110       120
                 ....*....|....*....|....*....|....*....|....*..
gi 4505415    81 LSPDIVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAY 127
Cdd:PRK09739  66 YSPEVHQLYSELLEHDALVFVFPLWWYSFPAMLKGYIDRVWNNGLAY 112
 
Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
5-216 4.97e-61

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 191.21  E-value: 4.97e-61
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415    5 RALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDItgklkdpanfqypaesvlaYKEGHLSPD 84
Cdd:COG2249   1 KILIIYAHPDPSSFNAALAEAAAEGLEAAGHEVTVHDLYAEGFDPVLSAADF-------------------YRDGPLPID 61
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415   85 IVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAYTYAAMYDKGPFRSKKAVLSITTGGSGSMYSLQGIHGD 164
Cdd:COG2249  62 VAAEQELLLWADHLVFQFPLWWYSMPALLKGWIDRVLTPGFAYGYGGGYPGGLLKGKKALLVVTTGGPEEAYSRLGYGGP 141
                       170       180       190       200       210
                ....*....|....*....|....*....|....*....|....*....|..
gi 4505415  165 MNVILwpiQSGILHFCGFQVLEPQLTYSIGHTPADARIQILEGWKKRLENIW 216
Cdd:COG2249 142 IEELL---FRGTLGYCGMKVLPPFVLYGVDRSSDEERAAWLERVRELLAALA 190
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
5-212 3.39e-46

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 153.26  E-value: 3.39e-46
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415      5 RALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMnFNPIISRKDITGklkdpanfqypaesvLAYKEGhlSPD 84
Cdd:pfam02525   2 KILIINAHPRPGSFSSRLADALVEALKAAGHEVTVRDLYAL-FLPVLDAEDLAD---------------LTYPQG--AAD 63
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415     85 IVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAYTYAA-MYDKGPFRSKKAVLSITTGGSGSMYSLQGIHG 163
Cdd:pfam02525  64 VESEQEELLAADVIVFQFPLYWFSVPALLKGWIDRVLRAGFAFKYEEgGPGGGGLLGKKVLVIVTTGGPEYAYGKGGYNG 143
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|.
gi 4505415    164 -DMNVILWPIQsGILHFCGFQVLEPQLTYSI-GHTPADARIQILEGWKKRL 212
Cdd:pfam02525 144 fSLDELLPYLR-GILGFCGITDLPPFAVEGTaGPEDEAALAEALERYEERL 193
PRK09739 PRK09739
NAD(P)H oxidoreductase;
1-127 6.18e-15

NAD(P)H oxidoreductase;


Pssm-ID: 236620 [Multi-domain]  Cd Length: 199  Bit Score: 71.27  E-value: 6.18e-15
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415     1 MVGRRALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDitgklkdpanfqypaESVLAYKEGH 80
Cdd:PRK09739   1 MQSMRIYLVWAHPRHDSLTAKVAEAIHQRAQERGHQVEELDLYRSGFDPVLTPED---------------EPDWKNPDKR 65
                         90       100       110       120
                 ....*....|....*....|....*....|....*....|....*..
gi 4505415    81 LSPDIVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAY 127
Cdd:PRK09739  66 YSPEVHQLYSELLEHDALVFVFPLWWYSFPAMLKGYIDRVWNNGLAY 112
PRK00871 PRK00871
glutathione-regulated potassium-efflux system oxidoreductase KefF;
84-219 1.06e-14

glutathione-regulated potassium-efflux system oxidoreductase KefF;


Pssm-ID: 234852  Cd Length: 176  Bit Score: 70.20  E-value: 1.06e-14
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415    84 DIVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAYTYAAMYDKGpfrsKKAVLSITTGGSGSMYSLqGIHG 163
Cdd:PRK00871  45 DIAAEQEALSRADLIVWQHPMQWYSIPPLLKLWIDKVLSHGWAYGHGGTALHG----KHLLWAVTTGGGESHFEI-GAHP 119
                         90       100       110       120       130
                 ....*....|....*....|....*....|....*....|....*....|....*....
gi 4505415   164 DMNVILWPIQSGILhFCGFQVLEP---QLTYSIGHTPADARIqilEGWKKRLENiWDET 219
Cdd:PRK00871 120 GFDVLSQPLQATAL-YCGLNWLPPfamHCTFICDDETLEGQA---RHYKQRLLE-WQEA 173
PRK04930 PRK04930
glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional
84-214 1.45e-10

glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional


Pssm-ID: 179895 [Multi-domain]  Cd Length: 184  Bit Score: 58.86  E-value: 1.45e-10
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415    84 DIVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAYTYAAMYDKGP-FRSkkavlSITTGGSGSMYSLQGI- 161
Cdd:PRK04930  51 DIPHEQALLREHDVIVFQHPLYTYSCPALLKEWLDRVLSRGFASGPGGNALAGKyWRS-----VITTGEPESAYRYDGYn 125
                         90       100       110       120       130
                 ....*....|....*....|....*....|....*....|....*....|...
gi 4505415   162 HGDMNVILWPIQSGILhFCGFQVLEPQLTYSIGHTPADARIQILEGWKKRLEN 214
Cdd:PRK04930 126 RYPMSDILRPFELTAA-MCRMHWLSPIIIYWARRQSPEELASHARAYGDWLAN 177
PRK00170 PRK00170
azoreductase; Reviewed
36-151 2.78e-06

azoreductase; Reviewed


Pssm-ID: 234675 [Multi-domain]  Cd Length: 201  Bit Score: 46.81  E-value: 2.78e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415    36 EVVESDLYAmNFNPIISrKDITGKLKDPANFQYPAESvlayKEGHLSPDIVAEqkkLEAADLVIFQFPLQWFGVPAILKG 115
Cdd:PRK00170  37 EVTVRDLAA-EPIPVLD-GEVVGALGKSAETLTPRQQ----EAVALSDELLEE---FLAADKIVIAAPMYNFSIPTQLKA 107
                         90       100       110
                 ....*....|....*....|....*....|....*.
gi 4505415   116 WFERVFIGEFAYTYAAMYDKGPFRSKKAVLSITTGG 151
Cdd:PRK00170 108 YIDLIARAGKTFRYTENGPVGLVTGKKALLITSRGG 143
WrbA COG0655
Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and ...
84-153 9.51e-06

Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and conversion];


Pssm-ID: 440420 [Multi-domain]  Cd Length: 181  Bit Score: 44.92  E-value: 9.51e-06
                        10        20        30        40        50        60        70
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415   84 DIVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERvfigefayTYAAMYDKGPFRSKKAVLsITTGGSG 153
Cdd:COG0655  60 DMNAIYEKLLEADGIIFGSPTYFGNMSAQLKAFIDR--------LYALWAKGKLLKGKVGAV-FTTGGHG 120
FMN_red pfam03358
NADPH-dependent FMN reductase;
53-154 1.34e-04

NADPH-dependent FMN reductase;


Pssm-ID: 427259 [Multi-domain]  Cd Length: 152  Bit Score: 41.07  E-value: 1.34e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415     53 RKDITGKLKDPANFQYPAESVLAYKEGHLSPDIVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFigefaytyaAM 132
Cdd:pfam03358  28 EEGAEVELIDLADLILPLCDEDLEEEQGDPDDVQELREKIAAADAIIIVTPEYNGSVSGLLKNAIDWLS---------RL 98
                          90       100
                  ....*....|....*....|..
gi 4505415    133 YDKGPFRsKKAVLSITTGGSGS 154
Cdd:pfam03358  99 RGGKELR-GKPVAIVSTGGGRS 119
PRK13556 PRK13556
FMN-dependent NADH-azoreductase;
36-151 2.31e-03

FMN-dependent NADH-azoreductase;


Pssm-ID: 184140 [Multi-domain]  Cd Length: 208  Bit Score: 38.20  E-value: 2.31e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 4505415    36 EVVESDLYAMNFnPIISRKDITGKLKdpanfqypaesvlAYKEGHLSPDivaEQKKLE----------AADLVIFQFPLQ 105
Cdd:PRK13556  38 TVVELDLYKEEL-PYVGVDMINGTFK-------------AGKGFELTEE---EAKAVAvadkylnqflEADKVVFAFPLW 100
                         90       100       110       120
                 ....*....|....*....|....*....|....*....|....*.
gi 4505415   106 WFGVPAILKGWFERVFIGEFAYTYAAMYDKGPFRSKKAVLSITTGG 151
Cdd:PRK13556 101 NFTIPAVLHTYIDYLNRAGKTFKYTPEGPVGLIGDKKVALLNARGG 146
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH